A 55-year-old man with obesity, type 2 diabetes, and ultrasound-confirmed non-alcoholic fatty liver disease (NAFLD) is reviewed. ALT is mildly elevated; there are no signs of cirrhosis. According to contemporary guidance, which investigation best stratifies his risk of advanced fibrosis in primary care?